The effect of multiple doses of ubrogepant on the pharmacokinetics of an oral contraceptive in healthy women: Results of an open-label, single-center, two-period, fixed-sequence study

• Main Authors: Chi-Chung Li (Author), John Palcza (Author), Jialin Xu (Author), Bob Thornton (Author), Wendy Ankrom (Author), Abhijeet Jakate (Author), Eugene E Marcantonio (Author)
• Format: Book
• Published: SAGE Publishing, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Ubrogepant is a novel, oral calcitonin gene-related peptide receptor antagonist for acute treatment of migraine. This study evaluated potential drug-drug interactions between ubrogepant and an oral contraceptive containing ethinyl estradiol (EE) and norgestimate (NGM). Methods: This open...